News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Iframe sync Post navigation Previous: Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext: Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories News Tersis Technologies Announces Strategic Initiatives Designed to Address Global Environmental and Economic Pressures Staff December 18, 2025 Brain News Edison Issues Report on MindMaze Therapeutics (MMTX) Staff December 18, 2025 News Coloplast announces changes to Executive Leadership Team Staff December 18, 2025
